The following patient profile concentrates dehydration risk
Because both medicines can affect the brain, appetite, energy levels, and how a person feels day to day, it is natural for people to wonder whether using them together is safe
Primarily, GLP-1 RAs help regulate blood glucose levels by stimulating insulin secretion from pancreatic beta cells, whilst decreasing the production of glucagon, a hormone that increases blood glucose
Glucagon-like peptide 1 (GLP-1) agonists including brand names like Ozempic and Wegovy were created to help people with type 2 diabetes make more insulin and lower their blood sugar
Short-acting drugs include exenatide twice daily, lixisenatide once daily and oral semaglutide once daily, while long-acting drugs include liraglutide, semaglutide, exenatide, albiglutide and dulaglutide all being administered once weekly
A 2024 review identified aluminium, arsenic, cadmium, chromium, mercury, thallium, lead and fungal contamination in unprocessed samples [25]